| PRMI |
No (n=109) |
Yes (n=30) |
p |
| Age |
71.49 ± 8 |
72.79 ± 7 |
0.470 |
| Male |
82(75.2) |
17(56.7) |
0.05 |
| BMI |
28.4 ± 4 |
28.09 ± 4 |
0.758 |
| Hypertension |
78(71.5) |
26(86.6) |
0.159 |
| Dyslipidemia |
65(59.6) |
12(40) |
0.179 |
| Diabetes Mellitus |
66 (60.5) |
18 (60) |
0.577 |
| Smoker |
36 (33) |
9 (30) |
0.988 |
| Previous MI |
45(41.3) |
15(50) |
0.381 |
| Abciximab |
35 (32.1) |
13(43.3) |
0,356 |
| Baseline stenosis |
75.34 ± 11.6 |
76.45 ± 9.5 |
0.676 |
| Poststent stenosis |
15.49 ± 13.9 |
14.48 ± 20.8 |
0.784 |
| Ostial lesion |
23(21.1) |
11(36.6) |
0.215 |
| Bifurcated lesion |
43(39.4) |
16(53.3) |
0.459 |
| Pacemaker |
2(1.8) |
1(3.3) |
0.051 |
| Contrast (mL) |
305.8 ± 114 |
310 ± 120 |
0.874 |
| DES |
93(85.3) |
24(80) |
0.266 |
| Treated Vessel |
1.05 ± 0.25 |
1.04 ± 0.2 |
0.889 |
| Stent Length |
41.63 ± 23 |
60 ± 32 |
0.002 |
| Burr Size |
1.62 ± 0.21 |
1.65 ± 0.12 |
0.491 |
| LM Treated |
26(23.8) |
11(36.7) |
0.204 |
| Inotropes |
3(2.7) |
2(6.6) |
0.255 |
| Branch Loss (>2 mm) |
1(0.9) |
3(10) |
0.015 |
BMI: Body mass index; LM: Left main;DES: Drug eluting stent |
